Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal oxytocin after recent trauma
NL-OMON27745Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jan 2012
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Randomised trial in post-traumatic stress disorder (PTSD) and trauma and stressor-related disorders comparing Intranasal oxytocin with Intranasal saline placebo (2 arms). Primary endpoints: PTSD symptom severity at 1.5 months and fMRI brain reactivity and connectivity. Started Jan 2012; status: active, not recruiting.
02
Drugs
oxytocin
03
Conditions
post-traumatic stress disorder (PTSD)trauma and stressor-related disorders
Beyond the preview
Go deeper on NL-OMON27745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON27745.